Predictions
Abbott Laboratories
Start price
Target price
Perf. (%)
€24.30
09.10.13
09.10.13
€25.50
09.04.14
09.04.14
13.82%
09.04.14
09.04.14
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€35.51
04.10.13
04.10.13
€40.00
04.04.14
04.04.14
23.65%
04.04.14
04.04.14
Could be worthwhile Investment >10% per year
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€176.40
01.07.13
01.07.13
€200.00
01.01.14
01.01.14
13.91%
01.01.14
01.01.14
Could be worthwhile Investment >10% per year
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€64.45
19.04.13
19.04.13
€45.00
11.11.13
11.11.13
-30.40%
11.11.13
11.11.13
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€43.96
09.08.13
09.08.13
€48.50
29.10.13
29.10.13
13.17%
29.10.13
29.10.13
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€39.77
24.04.13
24.04.13
€43.10
25.07.13
25.07.13
12.60%
25.07.13
25.07.13
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€34.73
27.01.13
27.01.13
€40.00
19.04.13
19.04.13
85.13%
19.04.13
19.04.13
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€26.85
06.10.12
06.10.12
€31.50
18.02.13
18.02.13
17.39%
18.02.13
18.02.13
Biogen Inc.
Start price
Target price
Perf. (%)
€91.50
22.01.12
22.01.12
€100.00
23.07.12
23.07.12
29.40%
23.07.12
23.07.12
Could be worthwhile Investment >10% per year
Johnson & Johnson
Start price
Target price
Perf. (%)
€49.74
07.04.12
07.04.12
€55.01
05.07.12
05.07.12
11.87%
05.07.12
05.07.12
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€28.20
12.04.12
12.04.12
€34.00
07.05.12
07.05.12
59.14%
07.05.12
07.05.12
Abbott Laboratories
Start price
Target price
Perf. (%)
€34.75
21.08.11
21.08.11
€37.00
13.02.12
13.02.12
22.72%
13.02.12
13.02.12
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€14.59
15.10.11
15.10.11
€18.65
01.02.12
01.02.12
27.94%
01.02.12
01.02.12
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€14.68
27.07.11
27.07.11
€18.00
26.01.12
26.01.12
25.99%
26.01.12
26.01.12
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€26.03
07.01.11
07.01.11
€28.00
07.07.11
07.07.11
53.42%
07.07.11
07.07.11
Could be worthwhile Investment >10% per year
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.56
14.12.10
14.12.10
€28.00
01.04.11
01.04.11
32.04%
01.04.11
01.04.11